Shots:
Dr. Emanuela Offidani explains how ADHD is increasingly recognized as a lifelong condition affecting both children and adults. She highlights that symptoms can differ across genders and are often underdiagnosed in women due to less visible hyperactivity and more internalized symptoms such as inattention and emotional dysregulation.
The conversation explores how Tris Pharma is…
Shots:
What started as a father’s determination to find a better solution has grown into a widely reimbursed therapy. Along the way, strong clinical evidence, early physician support, and carefully designed payer pilots helped unlock nationwide coverage, reaching nearly 130 million lives across Blue Cross Blue Shield plans.
In this conversation, Alon explains how Nerivio’s dual acute and preventive…
Shots:
The integration of innovative technologies in healthcare, such as digital health platforms and AI-enabled applications, is transforming the way diseases are detected, diagnosed, treated, and prevented
The global Digital Health market is expected to reach $197.88B in 2025 and grow at a CAGR of 6.88%, reaching $258.25B by 2029
PharmaShots presents a concise report…
Shots:
Whitney gave a brief on the partnership of Curebase with Digital Therapeutics Alliance to provide fit-for-purpose evidence standard for DTx product regulatory, reimbursement, and clinical acceptance
Whitney also elaborated on the Fit-for-Purpose Evidentiary standards and talked about why the DTx devices do not fit in the standards for medical devices by quoting some examples …
The recent decades have shown an accelerated development and evolution in the technology world- leading to unexpected growth in digital health companies.
With the aid of health information technology- wearable devices- telehealth- telemedicine- and personalized medicine HCPs can make better insights for treatments and early diagnosis of life-threatening diseases
Our team at PharmaShots has categorized…

